Crewe Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252 | Hold |
2
| – | – | ﹤0.01% | 717 |
|
|
2025
Q1 | $222 | Hold |
2
| – | – | ﹤0.01% | 691 |
|
|
2024
Q4 | $273 | Buy |
+2
| New | +$273 | ﹤0.01% | 620 |
|
|
2024
Q2 | – | Sell |
-700
| Closed | -$96.5K | – | 1006 |
|
|
2024
Q1 | $96.5K | Buy |
+700
| New | +$96.5K | 0.01% | 279 |
|
|
2023
Q2 | – | Sell |
-124
| Closed | -$12.6K | – | 970 |
|
|
2023
Q1 | $12.6K | Hold |
124
| – | – | ﹤0.01% | 504 |
|
|
2022
Q4 | $14.8K | Hold |
124
| – | – | ﹤0.01% | 473 |
|
|
2022
Q3 | $13K | Hold |
124
| – | – | ﹤0.01% | 585 |
|
|
2022
Q2 | $12K | Buy |
+124
| New | +$12K | ﹤0.01% | 554 |
|
|
2020
Q4 | – | Sell |
-6
| Closed | -$1K | – | 581 |
|
|
2020
Q3 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 595 |
|